Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.4.2 and the previous funding-status notice (Revision: v3.4.1) has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded an administrative notice about government funding and site status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated labels to Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Removed the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing study sites in Arizona, California, Florida, Georgia, Iowa, Missouri, Ohio, Oregon, Pennsylvania, and Washington. Removed individual location subsections (Arizona Locations, California Locations, etc.) and updated the page footer to Revision: v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page's footer revision tag changed from v3.2.0 to v3.3.1; this is a minor metadata update and does not affect content or features.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.